Check with your pharmacy about generic alternatives or other GLP-1 medications that might be more affordable or available
3.1 Clinical trial landscape: observations on effect size and heterogeneity Currently, RCTs of GLP-1RAs in PCOS are generally characterized by small sample sizes, single-center designs, and relatively short follow-up periods
Additionally, GLP-1RAs therapy increases circulating vascular progenitor cell content while reducing proinflammatory granulocyte precursor levels, representing an additional mechanism underlying their cardioprotective effects (96)
The Medicare GLP-1 Bridge will be nationwide and available in all states and territories
The Importance of Patient Education and Advocacy In navigating healthcare choices, patient education and advocacy are equally essential and critical to decision-making
Tirzepatide (Mounjaro): Commence with 5 mg subcutaneously once weekly, with subsequent weekly titration up to 15 mg or 20 mg, depending on patient response and tolerability